2025 NOSCM | The Utility of Liquid Biopsy in Advanced Cancers: Genomics,  Epigenomics and Proteomics

2025 NOSCM | The Utility of Liquid Biopsy in Advanced Cancers: Genomics, Epigenomics and Proteomics

Overview

Dr. David Gandara emphasized the role of liquid biopsy in precision medicine, noting high sensitivity for circulating tumor DNA.

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

David Gandara, MD

Date of Release

July 24th, 2025